Skip to Content
Merck
  • Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype.

Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype.

NPJ biofilms and microbiomes (2020-01-15)
Janne G Thöming, Jürgen Tomasch, Matthias Preusse, Michal Koska, Nora Grahl, Sarah Pohl, Sven D Willger, Volkhard Kaever, Mathias Müsken, Susanne Häussler
ABSTRACT

Studying parallel evolution of similar traits in independent within-species lineages provides an opportunity to address evolutionary predictability of molecular changes underlying adaptation. In this study, we monitored biofilm forming capabilities, motility, and virulence phenotypes of a plethora of phylogenetically diverse clinical isolates of the opportunistic pathogen Pseudomonas aeruginosa. We also recorded biofilm-specific and planktonic transcriptional responses. We found that P. aeruginosa isolates could be stratified based on the production of distinct organismal traits. Three major biofilm phenotypes, which shared motility and virulence phenotypes, were produced repeatedly in several isolates, indicating that the phenotypes evolved via parallel or convergent evolution. Of note, while we found a restricted general response to the biofilm environment, the individual groups of biofilm phenotypes reproduced biofilm transcriptional profiles that included the expression of well-known biofilm features, such as surface adhesive structures and extracellular matrix components. Our results provide insights into distinct ways to make a biofilm and indicate that genetic adaptations can modulate multiple pathways for biofilm development that are followed by several independent clinical isolates. Uncovering core regulatory pathways that drive biofilm-associated growth and tolerance towards environmental stressors promises to give clues to host and environmental interactions and could provide useful targets for new clinical interventions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pyocyanin, from Pseudomonas aeruginosa, ≥98% (HPLC)
Sigma-Aldrich
Phenazine, 98%